Showing results (211-220 of 310) with videos related to

Sort By:
Pageof 31
Clinical and Experimental Rheumatology|July 15, 2020
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritisChristof Specker, Annette Alberding, Martin Aringer, et al.
Frontiers in Immunology|July 18, 2022
Altered Balance of Pro-Inflammatory Immune Cells to T Regulatory Cells Differentiates Symptomatic From Asymptomatic Individuals With Anti-Nuclear AntibodiesRashi Gupta, Emma Vanlieshout, Kieran Manion, et al.
Arthritis Research & Therapy|February 11, 2023
Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosisSonya T Kim, Carolina Muñoz-Grajales, Shannon E Dunn, et al.
The Journal of Rheumatology|May 16, 2021
Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis SubsetsTatiana Nevskaya, Janet E Pope, Matthew A Turk, et al.
Rheumatology (Oxford, England)|July 9, 2025
Type I interferon limits interleukin-6 signaling in SLE through shedding interleukin-6 receptors]Martyna Hempel, Erik Klapproth, Annika Krause, et al.
Arthritis Research & Therapy|November 30, 2018
The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic diseaseYuriy Baglaenko, Nan-Hua Chang, Sindhu R Johnson, et al.
Arthritis Care & Research|November 5, 2011
Validation of potential classification criteria for systemic sclerosisSindhu R Johnson, Jaap Fransen, Dinesh Khanna, et al.
Clinical Rheumatology|December 13, 2006
Office capillaroscopy in systemic sclerosisMurray Baron, Mary Bell, Arthur Bookman, et al.
Lupus Science & Medicine|January 24, 2025
Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)Martin Aringer, Laurent Arnaud, Richard A Furie, et al.
Arthritis and Rheumatism|April 29, 2008
Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical featuresEsther Jimenez-Boj, Nancy Kedersha, Makiyeh Tohidast-Akrad, et al.
Pageof 31